Social share for Facebook Social share for Twitter/X Social share for LinkedIn Social share for Bluesky Share with Email
Published: 2025-07-09 10:30:00 CEST BioGaia AB - Investor News
BioGaia AB's Nomination Committee for the 2026 Annual General Meeting
BioGaia AB's Nomination Committee for the Annual General Meeting 2026 has been appointed based on the ownership structure as of June 30, 2025.
The Nomination Committee for the Annual General Meeting 2026 has been formed in accordance with the decision of the Annual General Meeting 2025. The Nomination Committee consists of Alexander Kahane (Chairman of the Nomination Committee), appointed by the largest shareholder Anatom Holding AG, Jannis Kitsakis, appointed by Fjärde AP-Fonden, Thomas Brown, Premier Miton Investors, and Julie Gaskjenn, Cargill Inc. In addition, Peter Rothschild is a member of the Nomination Committee in his capacity as Chairman of the Board.
Shareholders wishing to submit proposals to the Nomination Committee are welcome to contact the Chairman of the Nomination Committee by letter to the address BioGaia AB, Nomination Committee, Kungsbroplan 3A, 112 27 Stockholm.
Follow us:
Subscribe to BioGaia press releases here
LinkedIn here
Contacts:
Peter Rothschild, Chairman of the Board
Email: pr@biogaia.se
Phone: +46 (0)8 555 293 00
About BioGaia
BioGaia is a Swedish probiotic company that has been at the forefront of microbiome research for more than 35 years. BioGaia develops, markets, and sells probiotic products focused on gut health, immune health, and oral health. The products are sold through local distribution partners or via own distribution in over 100 markets. The class B share of the Parent Company BioGaia AB is quoted on the Mid Cap segment of Nasdaq Stockholm. biogaiagroup.com
BioGaia AB published this content on July 09, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 09, 2025 at 08:32 UTC.
Biogaia AB is a Sweden-based healthcare company that is engaged in the development and sell of probiotic products. The Company develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The Company operates worldwide.
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
